Micro-ultrasound vs. MRI for prostate biopsy
Part of Cancer, Kidney & urinary clinical trials.
This trial compares two advanced imaging techniques—high-frequency micro-ultrasound and multiparametric MRI—to guide biopsies for men who may have aggressive prostate cancer. The goal is to see which method better detects cancer while reducing unnecessary biopsies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a rising PSA level, an abnormal rectal exam, or both that suggests possible prostate cancer.
- You have had an MRI of your prostate that shows a suspicious area (PI-RADS score 3 or higher).
- You have not been diagnosed with prostate cancer before.
- Your PSA level is 20 or lower.
- Your rectal exam does not show a large tumor on both sides of the prostate.
- You do not have an untreated prostate infection or a bleeding disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two imaging methods, high-resolution micro-ultrasound and MRI, to see which is better at finding prostate cancer in men who have not had a biopsy before. If you are between 50 and 70 with an elevated PSA or abnormal exam, you may be able to join.
This trial compares a new micro-ultrasound technique to standard ultrasound during prostate biopsy, using MRI results as a guide. It aims to see if the newer method finds cancer more accurately.
This trial tests a new type of ultrasound, called micro-ultrasound, to see if it can better find significant prostate cancer in men who are on active surveillance. If you qualify, this could help your doctor decide if your cancer is truly low-risk.
This trial compares two ways to guide a prostate biopsy using MRI images, to see which better detects clinically significant prostate cancer in men with suspicious MRI findings.
This study looks at using advanced MRI techniques to better spot prostate cancer, aiming to reduce unnecessary biopsies. It has two parts: one calibrates MRI scanners across hospitals, the other tests the new method in patients with suspicious MRI findings.
This study tests whether using MRI imaging to guide prostate biopsies can help doctors sample only suspicious areas instead of taking many samples throughout the prostate. It may reduce discomfort and complications while still finding prostate cancer if present.
Hear when a new Prostatic Neoplasm of Uncertain Behavior trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.